Firms Agree to Discontinue Marketing Claims in Response to NAD Recommendations

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

By signing up for a tour of the Thompson FDA Compliance Expert Suite, you are also registering to receive email offers and product updates from us. Simply click unsubscribe at the bottom of any email if you would like to discontinue delivery.

Firms Agree to Discontinue Marketing Claims in Response to NAD Recommendations

Darla M. Fera

February 18, 2021 at 09:32 AM EST

Nanoceutical Solutions Inc. has discontinued claims and testimonials describing certain health benefits of its Nano Glutathione product, according to the National Advertising Division (NAD) of the Better Business Bureau’s (BBB) National Programs. NAD reported that it recommended the company discontinue “efficacy and establishment claims” for Nano Glutathione “due to a failur... Read More

My Research Folders

You are not Logged in yet, Please login to see Your research folders.

Oops! Subscribers must be logged in to access this content.

Not A Thompson FDA Subscriber?

Unlock access to the benefits below with a no-cost, risk-free trial of the FDA Compliance Expert Suite.

Subscription Benefits

Start Your Free Trial

Firms Agree to Discontinue Marketing Claims in Response to NAD Recommendations

My Research Folders

THOMPSON FDA

COMPLIANCE EXPERT

RESOURCES

HELP

CONTACT